Soluble LAG-3 fusion protein enhances the capacity of MHC-II macrophages or immature dendritic cells to induce T-cell responses whereby tumor regression involves the recruitment of CD8+ T-cell response. This evidence concerns the gene LAG3 and neoplasm.